UI Surgical

UI Surgical (联影智融) operates as the surgical robotics arm of United Imaging Group, one of China’s largest medical imaging conglomerates. Established in 2019, the company focuses on developing surgical robots, hybrid operating room systems, and interventional medical devices that integrate directly with United Imaging’s extensive imaging equipment portfolio.

Company Overview

Headquartered in Wuhan with significant operations in Shanghai, UI Surgical benefits from the technological foundation and resources of its parent company, United Imaging Healthcare (688271.SH). The company was founded as part of United Imaging Group’s strategic expansion beyond diagnostic imaging into therapeutic and interventional medical devices.

UI Surgical has established broad R&D, testing, and quality management systems. The company has secured over 20 domestic and international registrations and holds more than 300 authorized patents. It has undertaken multiple national and provincial research projects from China’s Ministry of Science and Technology, National Development and Reform Commission, and Ministry of Industry and Information Technology.

In a significant investment move, UI Surgical announced plans to invest RMB 2.5 billion to establish its Medical Innovation Headquarters Base in Wuhan’s Optics Valley, scheduled for completion in 2025. This facility will serve as both a high-end medical equipment R&D center and an intelligent manufacturing base for surgical robots, wearable medical devices, and medical 3D printing technologies.

Core Products

uNav-Brain 550 Neurosurgical Robot

The uNav-Brain 550 represents UI Surgical’s flagship neurosurgical robot system. Marketed as the world’s first integrated intelligent neurosurgical robot, it combines full-process intelligent software applications with efficient hardware coordination to assist surgeons in stereotactic procedures including deep brain stimulation (DBS), stereoelectroencephalography (SEEG), and brain biopsies.

The system completed multi-center clinical trials in July 2023, conducted across four major hospitals: Tongji Hospital, Sanbo Brain Hospital, Ruijin Hospital, and West China Hospital. Nearly 200 electrode trajectories were completed across multiple surgical procedures, demonstrating high accuracy in entry point and target positioning with no device-related adverse events.

uIGSBrain 730/750 Navigation System

The uIGSBrain series neurosurgical navigation and positioning systems received NMPA Class III medical device registration in April 2025. These systems integrate multimodal image fusion reconstruction, rapid lesion quantitative analysis, and high-precision stereotactic positioning simulation to enable precise lesion localization, reduce surgical risk, and optimize surgical workflow.

uIntervC550 Percutaneous Intervention Robot

The uIntervC550 percutaneous intervention robot obtained NMPA Class III registration in 2025, marking a breakthrough in CT-guided “real-time visualization” surgical procedures. The system has been deployed at leading hospitals including Wuhan Tongji, Tianjin Cancer Hospital, Beijing Union Medical College Hospital, and Shanghai Ruijin Hospital.

Key features include a precision robotic arm system powered by generative intelligent technology capable of decoding surgeon intentions for sub-millimeter control and 360-degree precision movement. The system integrates multimodal fusion capabilities, combining preoperative CT, MRI, and other imaging data to provide full patient information and intelligent path planning assistance.

uHOR Hybrid Operating Room

The uHOR (魔方) Hybrid Operating Room system debuted at the 87th CMEF exhibition in May 2023. As a fully self-developed three-in-one hybrid operating room solution, it integrates advanced intraoperative imaging equipment including the industry’s first 75cm bore intraoperative MRI, robot-integrated sliding CT, and 10-axis DSA systems alongside surgical robots, endoscopes, and ultrasonic scalpels.

Technology & Innovation

UI Surgical’s technological advantage stems from its integration with United Imaging Group’s imaging expertise. The company’s neurosurgical robots incorporate multimodal imaging fusion, enabling real-time combination of CT, MRI, and PET data for surgical planning and navigation. Key technological features include:

• Automatic vessel interference detection and path angle monitoring
• Electrode entry point recognition algorithms
• Markerless facial rapid registration capabilities
• Blood clot quantitative analysis functions for hemorrhage cases
• Neural fiber bundle tracking and visualization for neuromodulation procedures

The company’s R&D efforts span multiple disciplines including mechanics, electronics, optics, computing, and software engineering, positioning it to address technological bottlenecks in high-end medical treatment and rehabilitation equipment.

Market Presence

UI Surgical operates primarily within China’s domestic market, with products deployed at numerous top-tier hospitals across the country. The company’s percutaneous intervention robot has been clinically applied at major academic medical centers, while its hybrid operating room solutions target hospitals seeking integrated surgical suites.

As a subsidiary of the publicly traded United Imaging Healthcare, UI Surgical benefits from established distribution channels and customer relationships across China’s hospital network. The parent company’s market position as a leading domestic medical imaging manufacturer provides credibility and market access for UI Surgical’s newer product lines.

Key Milestones

• 2019: UI Surgical established as United Imaging Group subsidiary
• 2023 May: uHOR Hybrid Operating Room debuts at CMEF Shanghai
• 2023 July: Neurosurgical robot multi-center clinical trials completed
• 2023 August: uHOR officially launched at Wuhan event
• 2025 April: uIGSBrain 730/750 navigation systems receive NMPA Class III approval
• 2025: uIntervC550 percutaneous intervention robot receives NMPA Class III approval

Frequently Asked Questions

What is UI Surgical’s relationship with United Imaging Healthcare?

UI Surgical (联影智融) is a subsidiary of United Imaging Group, the parent company of United Imaging Healthcare (688271.SH). While United Imaging Healthcare focuses primarily on diagnostic imaging equipment such as CT, MRI, and PET systems, UI Surgical was established in 2019 to develop surgical robots, hybrid operating rooms, and interventional devices. The two companies share technology platforms and resources, with UI Surgical’s products designed to integrate with United Imaging’s imaging equipment.

Has UI Surgical’s neurosurgical robot received regulatory approval?

UI Surgical’s neurosurgical navigation systems (uIGSBrain 730/750) received NMPA Class III medical device registration in April 2025. The uNav-Brain 550 neurosurgical robot completed multi-center clinical trials in July 2023, with registration status for the robotic system itself pending confirmation.

What types of surgeries can UI Surgical’s robots perform?

UI Surgical’s neurosurgical systems are designed for stereotactic procedures including deep brain stimulation (DBS), stereoelectroencephalography (SEEG), brain biopsies, and stereotactic drainage of intracerebral hemorrhage. The uIntervC550 percutaneous intervention robot is designed for CT-guided percutaneous procedures including tumor ablation and biopsy procedures.